Hendrik Rathke

4.8k total citations · 3 hit papers
52 papers, 3.1k citations indexed

About

Hendrik Rathke is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hendrik Rathke has authored 52 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hendrik Rathke's work include Radiopharmaceutical Chemistry and Applications (24 papers), Prostate Cancer Treatment and Research (21 papers) and Peptidase Inhibition and Analysis (19 papers). Hendrik Rathke is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Prostate Cancer Treatment and Research (21 papers) and Peptidase Inhibition and Analysis (19 papers). Hendrik Rathke collaborates with scholars based in Germany, United States and Switzerland. Hendrik Rathke's co-authors include Clemens Kratochwil, Frederik L. Giesel, Uwe Haberkorn, Frank Bruchertseifer, Aliyah Morgenstern, Jürgen Debus, Manuel Röhrich, Thomas Lindner, Paul Flechsig and Walter Mier and has published in prestigious journals such as Journal of Clinical Oncology, European Urology and Journal of Nuclear Medicine.

In The Last Decade

Hendrik Rathke

52 papers receiving 3.1k citations

Hit Papers

68Ga-FAPI PET/CT: Tracer ... 2017 2026 2020 2023 2019 2017 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hendrik Rathke Germany 26 2.0k 1.7k 1.1k 880 817 52 3.1k
Paul Flechsig Germany 25 2.1k 1.1× 1.4k 0.8× 1.1k 0.9× 1.1k 1.2× 984 1.2× 45 3.4k
Jérémie Calais United States 37 1.3k 0.7× 2.7k 1.6× 3.5k 3.1× 857 1.0× 562 0.7× 218 4.9k
Sebastian Adeberg Germany 33 2.2k 1.1× 1.1k 0.6× 1.2k 1.1× 1.0k 1.2× 1.3k 1.6× 165 4.2k
Justin Ferdinandus Germany 18 1.0k 0.5× 1.5k 0.9× 1.5k 1.3× 424 0.5× 330 0.4× 51 2.3k
Jens Cardinale Germany 22 897 0.5× 1.3k 0.8× 1.1k 0.9× 391 0.4× 312 0.4× 49 2.1k
Sanjana Ballal India 24 976 0.5× 1.1k 0.7× 692 0.6× 266 0.3× 412 0.5× 88 1.9k
Madhav Prasad Yadav India 22 963 0.5× 1.1k 0.6× 677 0.6× 255 0.3× 334 0.4× 59 1.8k
Christoph Rischpler Germany 35 789 0.4× 1.9k 1.2× 744 0.7× 325 0.4× 649 0.8× 177 3.6k
Eric A. Mellon United States 24 1.4k 0.7× 1.0k 0.6× 1.1k 0.9× 552 0.6× 503 0.6× 111 2.9k
Stefan Rieken Germany 38 1.5k 0.7× 908 0.5× 1.9k 1.6× 462 0.5× 992 1.2× 210 4.3k

Countries citing papers authored by Hendrik Rathke

Since Specialization
Citations

This map shows the geographic impact of Hendrik Rathke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Rathke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Rathke more than expected).

Fields of papers citing papers by Hendrik Rathke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Rathke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Rathke. The network helps show where Hendrik Rathke may publish in the future.

Co-authorship network of co-authors of Hendrik Rathke

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Rathke. A scholar is included among the top collaborators of Hendrik Rathke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Rathke. Hendrik Rathke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rathke, Hendrik, Frank Bruchertseifer, Manuel Röhrich, et al.. (2024). Deescalated225Ac-PSMA-617 Versus177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients. Journal of Nuclear Medicine. 65(7). 1057–1063. 12 indexed citations
2.
Zeimpekis, Konstantinos, Lorenzo Mercolli, Maurizio Conti, et al.. (2024). 90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry. European Journal of Nuclear Medicine and Molecular Imaging. 51(7). 2100–2113. 7 indexed citations
3.
Kurth, Jens, Surachet Imlimthan, Euy Sung Moon, et al.. (2023). Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3202–3213. 7 indexed citations
4.
Hubert, Alexander, Clemens Kratochwil, Frederik L. Giesel, et al.. (2022). Repetitive Early68Ga-FAPI PET Acquisition Comparing68Ga-FAPI-02,68Ga-FAPI-46, and68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions. Journal of Nuclear Medicine. 63(12). 1844–1851. 31 indexed citations
5.
Rathke, Hendrik, Stefan Fuxius, Frederik L. Giesel, et al.. (2021). Two Tumors, One Target. Clinical Nuclear Medicine. 46(10). 842–844. 30 indexed citations
6.
Röhrich, Manuel, Mustafa Syed, Frederik L. Giesel, et al.. (2021). 68Ga-FAPI-PET/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas – Imaging analysis and histological validation. Radiotherapy and Oncology. 160. 192–201. 42 indexed citations
7.
Koerber, Stefan A., Katharina Dendl, Matthias Uhl, et al.. (2021). Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 3918–3924. 39 indexed citations
8.
Kratochwil, Clemens, Leonidas Apostolidis, Hendrik Rathke, et al.. (2021). Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity. European Journal of Nuclear Medicine and Molecular Imaging. 49(1). 54–63. 60 indexed citations
9.
Seidensaal, Katharina, Sabine Haufe, Hendrik Rathke, et al.. (2021). The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma. Radiotherapy and Oncology. 159. 8–16. 20 indexed citations
10.
Rathke, Hendrik, Frank Bruchertseifer, Clemens Kratochwil, et al.. (2020). First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 311–312. 18 indexed citations
11.
Gafita, Andrei, Wolfgang P. Fendler, Hui Wang, et al.. (2020). Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study. European Urology. 78(2). 148–154. 43 indexed citations
12.
Baumann, In go, Peter K. Plinkert, Johannes Krisam, et al.. (2019). Validating the Xerostomia Inventory in a radiation‐induced xerostomia population in German language. Oral Diseases. 25(7). 1744–1750. 15 indexed citations
13.
Rathke, Hendrik, Tim Holland‐Letz, Walter Mier, et al.. (2019). Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase. Journal of Nuclear Medicine. 61(5). 689–695. 48 indexed citations
14.
Müller, Martin, Annette Altmann, Max Sauter, et al.. (2019). Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma. Nuklearmedizin - NuclearMedicine. 58(4). 309–318. 9 indexed citations
15.
Kratochwil, Clemens, Frederik L. Giesel, Claus Peter Heußel, et al.. (2019). Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes. Journal of Nuclear Medicine. 61(5). 683–688. 69 indexed citations
16.
Koerber, Stefan A., Leon Will, Clemens Kratochwil, et al.. (2018). 68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients. Journal of Nuclear Medicine. 60(2). 234–240. 44 indexed citations
17.
Rathke, Hendrik, Clemens Kratochwil, Frederik L. Giesel, et al.. (2018). Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT. European Journal of Nuclear Medicine and Molecular Imaging. 46(1). 139–147. 70 indexed citations
18.
Streitparth, Florian, Christian E. Althoff, Martin Maurer, et al.. (2017). Tailored interactive sequences for continuous MR-image-guided freehand biopsies of different organs in an open system at 1.0 tesla (T) – Initial experience. Biomedizinische Technik/Biomedical Engineering. 62(6). 557–563. 3 indexed citations
19.
Rathke, Hendrik, Frederik L. Giesel, Paul Flechsig, et al.. (2017). Repeated 177Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq. Journal of Nuclear Medicine. 59(3). 459–465. 64 indexed citations
20.
Bucourt, Maximilian de, et al.. (2015). Teleradiologische Prozess- und Untersuchungszeiten. Der Radiologe. 55(5). 409–416. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026